Analyzing Community Health Systems (NYSE:CYH) & Henry Schein (NASDAQ:HSIC)

Henry Schein (NASDAQ:HSIC – Get Free Report) and Community Health Systems (NYSE:CYH – Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.

Risk & Volatility

Henry Schein has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500. Comparatively, Community Health Systems has a beta of 1.9, meaning that its stock price is 90% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Henry Schein and Community Health Systems, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Henry Schein 1 5 8 0 2.50
Community Health Systems 4 3 1 0 1.62

Henry Schein currently has a consensus price target of $93.86, suggesting a potential upside of 10.68%. Community Health Systems has a consensus price target of $2.34, suggesting a potential upside of 44.10%. Given Community Health Systems’ higher possible upside, analysts plainly believe Community Health Systems is more favorable than Henry Schein.

Earnings and Valuation

This table compares Henry Schein and Community Health Systems”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Henry Schein $13.18 billion 0.71 $398.00 million $3.65 23.23
Community Health Systems $12.48 billion 0.02 $509.00 million $0.26 6.25

Community Health Systems has lower revenue, but higher earnings than Henry Schein. Community Health Systems is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 85.0% of Community Health Systems shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by insiders. Comparatively, 11.1% of Community Health Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Henry Schein and Community Health Systems’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Henry Schein 3.07% 16.39% 5.58%
Community Health Systems 0.31% -6.66% -1.24%

Summary

Henry Schein beats Community Health Systems on 10 of the 14 factors compared between the two stocks.

About Henry Schein

(Get Free Report)

Henry Schein, Inc. is a global distributor of health care products and services, serving dental and medical practitioners, veterinary professionals, and other health care organizations. The company traces its roots to a pharmacy founded by Henry and Esther Schein in Queens, New York, in 1932. Its offerings include medical and dental supplies, equipment, pharmaceuticals, vaccines, and diagnostic products. Henry Schein also provides practice-management software, technology solutions, and business services designed to help health care professionals manage their operations.

About Community Health Systems

(Get Free Report)

Community Health Systems, Inc. is a U.S. healthcare company that, through its subsidiaries, owns, leases and operates general acute care hospitals and related healthcare facilities. Its hospitals serve local communities, with a focus on markets outside major urban centers. The company’s facilities provide a range of services, including emergency care, inpatient and outpatient treatment, surgery, diagnostic imaging and other clinical services. Related outpatient facilities extend access to care beyond the hospital setting.

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.